Inventor · disambiguated record
Jason Thomas Roland
Also filed as: ROLAND JASON · ROLAND JASON T · ROLAND JASON THOMAS
12 granted patents·11 pending applications·22 citations·filing 2013–2023
87Inventor score
Files withNOVARTIS AG8SCRIPPS RESEARCH INST5NERIO THERAPEUTICS INC4CHATTERJEE ARNAB KUMAR3CHIANELLI DONATELLA1
Top patents by PatentIndex Score
23 records- 0188US9556169B2Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2013·Granted Jan 31, 2017·8 cites·17 claims
- 0286US10077240B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2017·Granted Sep 18, 2018·4 cites·15 claims
- 0379US9682939B2Compositions and methods for modulating farnesoid X receptorsCHIANELLI DONATELLA·Filed 2014·Granted Jun 20, 2017·3 cites·27 claims
- 0478US8871754B2Compounds and compositions for the treatment of parasitic diseasesCHATTERJEE ARNAB KUMAR·Filed 2013·Granted Oct 28, 2014·4 cites·12 claims
- 0575US2023111793A1Antimalarial compositions and uses thereofSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 0673US9926314B2Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2016·Granted Mar 27, 2018·1 cites·19 claims
- 0772US10947176B2Antimalarial compositions and uses thereofSCRIPPS RESEARCH INST·Filed 2017·Granted Mar 16, 2021·1 cites·22 claims
- 0872US10683271B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2018·Granted Jun 16, 2020·0 cites·15 claims
- 0972US2021253534A1Compositions and methods for modulating farnesoid x receptorsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1071US11021446B2Compositions and methods for modulating farnesoid X receptorsNOVARTIS AG·Filed 2020·Granted Jun 1, 2021·0 cites·13 claims
- 1170US10774068B2Composition and methods for inhibiting mammalian sterile 20-like kinase 1SCRIPPS RESEARCH INST·Filed 2016·Granted Sep 15, 2020·1 cites·16 claims
- 1269US11485697B2Antimalarial compositions and uses thereofSCRIPPS RESEARCH INST·Filed 2021·Granted Nov 1, 2022·0 cites·11 claims
- 1367US2025353926A1Crosslinking multispecific antibodiesENLAZA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1463US2025136564A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1563US2025134882A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1662US2025129032A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1761US2018230145A1Compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1860US2025257059A1Protein tyrosine phosphatase inhibitors and uses thereofNERIO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1959US11427560B2Composition and methods for inhibiting mammalian sterile 20-like kinase 1SCRIPPS RESEARCH INST·Filed 2020·Granted Aug 30, 2022·0 cites·19 claims
- 2055US2015011522A1Compounds and compositions for the treatment of parasitic diseasesCHATTERJEE ARNAB KUMAR·Filed 2014·Application pending·0 cites
- 2143US2015291598A1Compounds and compositions for the treatment of parasitic diseasesCHATTERJEE ARNAB KUMAR·Filed 2013·Application pending·0 cites
- 2238US10351576B2Fused tricyclic pyrazole derivatives useful for farnesoid X receptorsNOVARTIS AG·Filed 2016·Granted Jul 16, 2019·0 cites·18 claims
- 2338US2018271873A1Methods for treating viral infectionsTHE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →